Elliot S Gershon Selected Research

N,N'-bis(1-decylnipecotoyl)piperazine (BDNP)

12/2021	Reduced white matter microstructure in bipolar disorder with and without psychosis.
1/2020	Electrophysiological correlates of emotional scene processing in bipolar disorder.
1/2019	Auditory steady-state EEG response across the schizo-bipolar spectrum.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elliot S Gershon Research Topics

Disease

27	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 07/2003
25	Bipolar Disorder (Manic Depressive Psychosis) 09/2022 - 02/2007
18	Schizophrenia (Dementia Praecox) 07/2022 - 01/2008
6	Cognitive Dysfunction 11/2022 - 11/2014
3	Mental Disorders (Mental Disorder) 12/2018 - 11/2004
3	Mood Disorders (Mood Disorder) 01/2012 - 07/2003
2	Genetic Risk Score 07/2022 - 01/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 07/2022
1	Major Depressive Disorder (Major Depressive Disorders) 07/2022
1	Inflammation (Inflammations) 07/2022
1	Neurodevelopmental Disorders 01/2022
1	Mania (Manias) 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 12/2021
1	Hypesthesia (Numbness) 01/2020
1	Hallucinations (Hallucination) 01/2020

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
7	Biological ProductsIBA 07/2022 - 11/2004
4	LithiumIBA 01/2022 - 01/2019
3	N,N'-bis(1-decylnipecotoyl)piperazine (BDNP)IBA 12/2021 - 01/2019
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2022 - 01/2020
2	Cholinergic Antagonists (Anticholinergics)IBA 01/2021 - 12/2017
2	Antipsychotic Agents (Antipsychotics)IBA 09/2014 - 03/2011
2	D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA 10/2009 - 01/2008
2	Dihydrotachysterol (AT 10)IBA 02/2007 - 07/2003
1	HDL LipoproteinsIBA 07/2022
1	Triglycerides (Triacylglycerol)IBA 07/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 07/2022
1	C-Reactive ProteinIBA 01/2022
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2022
1	Sp4 Transcription FactorIBA 01/2022
1	NucleotidesIBA 12/2021
1	FurinIBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2020
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 12/2018
1	MicroRNAs (MicroRNA)IBA 12/2018
1	Oxytocin Receptors (Oxytocin Receptor)IBA 03/2016
1	Vasopressins (Vasopressin)IBA 11/2014
1	Oxytocin (Pitocin)FDA LinkGeneric 11/2014
1	Indicators and Reagents (Reagents)IBA 09/2014
1	N 30IBA 11/2013
1	A-factor (Streptomyces)IBA 09/2013
1	Genetic Markers (Genetic Marker)IBA 09/2013
1	ParvalbuminsIBA 12/2012
1	Serotonin (5 Hydroxytryptamine)IBA 01/2012
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 03/2011
1	Cyclic AMP (AMP, Cyclic)IBA 03/2011
1	Type II Vasoactive Intestinal Peptide ReceptorsIBA 03/2011
1	Neuropeptide Receptors (Neuropeptide Receptor)IBA 03/2011
1	Neuregulin-1 (Neuregulin 1)IBA 07/2009
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2008
1	Neurotransmitter Agents (Neurotransmitter)IBA 10/2008
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 10/2007
1	Cholinergic Agents (Cholinergics)IBA 09/2007

Therapy/Procedure

3	Behavior Control 01/2020 - 09/2014
1	Institutionalization (Institutionalized Persons) 11/2022
1	Therapeutics 01/2022